Marlborough, MA, September 20th, 2022 - Market leading innovator in laboratory digital transformation, Scitara, has...
PPMA Total Show 2022 ‚Ä’ The ‘Must Attend‚Ä™ Event This Autumn
22.08.2022 - With a myriad of new product launches, innovative technologies and live demonstrations of the latest...
Nuvera PURE Reports name 2022 (best-in-class) pharmaceutical companies in oncology, neurology and immunology
[September 20, 2022] Nuvera Life Science Consulting, part of Ashfield Engage, is pleased to announce its second annual...
FlyPharma Conference Europe: New dates and location announced
Taking place in Leipzig, Germany on 19-21 September, FlyPharma Europe will bring together a global audience of...
“airea ‚Ä’ The Airport Region in Central Germany( Presents Itself As An Attractive Location For The International Pharmaceutical Industry
Leipzig, September 19 2022 - "airea - The Airport Region in Central Germany" is one of the top national and global...
KITE‪S CAR T-CELL THERAPY YESCARTA (AXICABTAGENE CILOLEUCEL) FIRST IN EUROPE TO RECEIVE POSITIVE CHMP OPINION FOR USE IN SECOND-LINE DIFFUSE LARGE B-CELL LYMPHOMA AND HIGH-GRADE B-CELL LYMPHOMA
Stockley Park, UK - 16 September, 2022 - Kite, a Gilead Company, today announces that the European Medicines Agency...
Elligo‪s Rebecca Kush, Ph.D., Elected Chair of Vulcan Advisory Council: Connecting Clinical Research and Healthcare
AUSTIN, Texas; Sept. 13, 2022 (Business Wire) - Elligo Health Research, the largest healthcare-enabling research...
Teknomek Launches Ground-Breaking Hygienox Tables, Designed for Ultra-Sterile Environments
12 September 2022 - Created specifically for A & B Grade cleanroom environments where compliance with ISO 14644 is...
ACG: (The global pharmaceutical solutions company on a mission to help manufacturers keep their supply chains moving)
Mumbai, 12 September, 2022 - The current crisis in Europe has led to increasing energy insecurity and shortages of raw...
Avantor to Acquire Masterflex; Expands Proprietary Single-Use Offering for Bioproduction
RADNOR, Pa., Sept. 7, 2021 /PRNewswire/ - Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical...
STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer
7 September 2022, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing...
KITE‪S CAR T-CELL THERAPY TECARTUS (BREXUCABTAGENE AUTOLEUCEL) GRANTED EUROPEAN MARKETING AUTHORISATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA (r/r ALL)
Stockley Park, UK - 7 September 2022 - Kite, a Gilead Company, today announced that the European Commission (EC) has...
